June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Yan Leyfman: IFN-γR Knockout Improves CD28 CAR T Cell Function in Tumor Models
Jun 6, 2025, 16:15

Yan Leyfman: IFN-γR Knockout Improves CD28 CAR T Cell Function in Tumor Models

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:

“New findings from Dr. Marcela Maus and team at Mass General Hospital reveal a surprising twist in CAR T-cell therapy:
While IFN-γ is often seen as a key player in immunotherapy, this study shows it may actually induce apoptosis in CD28-based CAR T cells, limiting their persistence and efficacy.
Knockout of IFN-γ receptor (IFN-γR) enhanced CAR T cell survival, memory, and anti-tumor activity – especially in solid tumors where CAR T success has been more elusive.
IFN-γR KO led to:
  • Better tumor control
  • Longer survival
  • Durable immune memory
  • Enhanced tumor cell apoptosis
This could mark a major advance in optimizing CAR T design for both liquid and solid cancers.”

Title: IFN-γ–resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models

Journal: Science Translational Medicine

Authors: Stefanie R. Bailey, Hana N. Takei, Giulia Escobar, Michael C. Kann, Amanda A. Bouffard, Tamina Kienka, Valentina M. Supper, Alexander Armstrong, Diego Salas-Benito, Merle K. Phillips, Filippo Birocchi, Sonika Vatsa, Harrison Silva, Irene Scarfò, Marc Wehrli, Korneel Grauwet, Eli P. Darnell, Charlotte E. Graham, Mark B. Leick, Felix Korell, Trisha R. Berger, Marcela V. Maus

Read the full article.

CAR T Cell

More posts featuring Yan Leyfman on OncoDaily.